Found 280 matching trials
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 PHASE1 The purpose of this study is to find the number of natural killer (NK) cell...
Show More Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Learn More & Join Trial
Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers PHASE1 This is an open-label, multi-center study to evaluate the safety, tolerabil...
Show More Location
USC/Norris Comprehensive Cancer Center
Learn More & Join Trial
CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation PHASE1 The investigators propose a nonrandomized, Phase I study to assess the safe...
Show More Location
Hammersmith Hospital
Learn More & Join Trial
CIML NK Cell in Head & Neck Cancer PHASE1 This research study is evaluating the safety and efficacy of a combination ...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors PHASE1 This is a Phase 1 open-label, study designed to characterize the safety, to...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD PHASE1 This is a single arm, open-label, multi-center, pilot studies (Investigator...
Show More Location
First Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas PHASE1 Progress in the treatment of children with leukemia and lymphoma results in...
Show More Location
National University Hospital
Learn More & Join Trial
Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I PHASE1 T effector cells and NK cells have mutual compensatory killing functions on...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
NK521 in the Treatment of Advanced Solid Tumors EARLY_PHASE1 Eligible subjects with advanced hepatocellular carcinoma and ovarian cancer...
Show More Location
1st affiliated hospital of Anhui Medical University
Learn More & Join Trial